ROS1 and non-small cell lung carcinoma: ROS proto-oncogene 1 (ROS1) fusions are oncogenic drivers that have been identified in around 2% of patients with non-small-cell lung cancer and are more prevalent in non-squamous tumor types, younger individuals, female patients, and those without a history of smoking [1,2,3,4,5].